ARWR
Price
$14.93
Change
-$0.35 (-2.29%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
2.1B
89 days until earnings call
UNCY
Price
$0.56
Change
-$0.05 (-8.20%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
73.07M
6 days until earnings call
Ad is loading...

ARWR vs UNCY

Header iconARWR vs UNCY Comparison
Open Charts ARWR vs UNCYBanner chart's image
Arrowhead Pharmaceuticals
Price$14.93
Change-$0.35 (-2.29%)
Volume$57.27K
Capitalization2.1B
Unicycive Therapeutics
Price$0.56
Change-$0.05 (-8.20%)
Volume$2.81K
Capitalization73.07M
ARWR vs UNCY Comparison Chart
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. UNCY commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Buy and UNCY is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (ARWR: $15.28 vs. UNCY: $0.61)
Brand notoriety: ARWR: Notable vs. UNCY: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 236% vs. UNCY: 75%
Market capitalization -- ARWR: $2.1B vs. UNCY: $73.07M
ARWR [@Biotechnology] is valued at $2.1B. UNCY’s [@Biotechnology] market capitalization is $73.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, ARWR is a better buy in the long-term than UNCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 8 TA indicator(s) are bullish while UNCY’s TA Score has 7 bullish TA indicator(s).

  • ARWR’s TA Score: 8 bullish, 2 bearish.
  • UNCY’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, ARWR is a better buy in the short-term than UNCY.

Price Growth

ARWR (@Biotechnology) experienced а +16.82% price change this week, while UNCY (@Biotechnology) price change was +0.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.95%. For the same industry, the average monthly price growth was +6.81%, and the average quarterly price growth was -5.99%.

Reported Earning Dates

ARWR is expected to report earnings on Aug 11, 2025.

UNCY is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+0.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.1B) has a higher market cap than UNCY($73.1M). ARWR YTD gains are higher at: -18.723 vs. UNCY (-23.735). UNCY has higher annual earnings (EBITDA): -22.56M vs. ARWR (-580.69M). ARWR has more cash in the bank: 553M vs. UNCY (32.3M). UNCY has less debt than ARWR: UNCY (807K) vs ARWR (525M). ARWR has higher revenues than UNCY: ARWR (2.5M) vs UNCY (0).
ARWRUNCYARWR / UNCY
Capitalization2.1B73.1M2,870%
EBITDA-580.69M-22.56M2,574%
Gain YTD-18.723-23.73579%
P/E RatioN/AN/A-
Revenue2.5M0-
Total Cash553M32.3M1,712%
Total Debt525M807K65,056%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
15

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRUNCY
RSI
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 6 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+9.38%
DNLI - ARWR
57%
Loosely correlated
-3.65%
NTLA - ARWR
55%
Loosely correlated
-2.69%
RGNX - ARWR
55%
Loosely correlated
+2.63%
BEAM - ARWR
54%
Loosely correlated
-1.04%
ETNB - ARWR
52%
Loosely correlated
-3.82%
More

UNCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with IRD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then IRD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
+7.11%
IRD - UNCY
35%
Loosely correlated
+0.97%
VKTX - UNCY
34%
Loosely correlated
-2.00%
ROIV - UNCY
27%
Poorly correlated
-2.09%
DNTH - UNCY
27%
Poorly correlated
-6.18%
ARWR - UNCY
27%
Poorly correlated
+9.38%
More